Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;39(4):2007-2014.
doi: 10.21873/anticanres.13311.

Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma

Mohamed Abdelgadir Adam  1 , Dimitrios Moris  2 , Shay Behrens  1 , Daniel P Nussbaum  1 , Oliver Jawitz  1 , Megan Turner  1 , Michael Lidsky  1 , Dan Blazer 3rd  1
Affiliations

Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma

Mohamed Abdelgadir Adam et al. Anticancer Res. 2019 Apr.

Erratum in

  • Errata.
    [No authors listed] [No authors listed] Anticancer Res. 2019 Sep;39(9):5225. Anticancer Res. 2019. PMID: 31519638 No abstract available.

Abstract

Background: Retroperitoneal sarcomas (RPS) are rare, histologically heterogeneous, and anatomically complex tumors. National Comprehensive Cancer Network guidelines recommend evaluation and management by multidisciplinary teams with experience in sarcoma. Our aim was to determine an appropriate hospital volume threshold for the treatment of RPS.

Patients and methods: Patients undergoing resection of RPS were identified from the National Cancer Data Base (1998-2012). Multivariable modeling with restricted cubic splines was employed to examine the association between hospital volume and survival and identify possible hospital volume threshold.

Results: The study included 5,340 patients who underwent surgery at 909 different hospitals. Median annual volume was two cases per year. After adjustment, hospital volume was associated with improved survival (p=0.01), without cutoff. The cohort was then grouped into: Low-volume (≤5 cases/year), intermediate-volume (6-10 cases/year), and high-volume (>10 cases/year). The majority of patients were treated in low-volume hospitals (86%), compared to 9% in intermediate- and 5% in high-volume centers; 44% of patients were treated in hospitals that performed one case per year. Compared to low-volume, high-volume hospitals more often had patients with high-grade and larger tumors. Adjusted 90-day mortality was significantly lower in high- vs. low-volume hospitals (odds ratio(OR)=0.25, p=0.02). With adjustment, treatment in high- vs. low-volume hospitals was associated with lower odds of margin positivity (OR=0.58, p=0.001), and improved overall survival (hazard ratio(HR)=0.61, p=0.002).

Conclusion: Treatment of RPS in high-volume centers is associated with significant reduction in short-term mortality and improved long-term survival. Hospital volume may be a surrogate for the infrastructure and support necessary for the optimal management of these complex malignancies.

Keywords: NCBD; Retroperitoneal sarcoma; surgical volume; survival; volume threshold.

PubMed Disclaimer

LinkOut - more resources